Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    "Pars planitis"
Show Display Options
Rank Status Study
21 Enrolling by invitation An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data
Condition: Uveitis
Intervention: Drug: Dose 2 gevokizumab
22 Not yet recruiting Safety &Efficacy of CF101 to Subjects With Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate
Interventions: Drug: CF101;   Drug: Placebo
23 Terminated Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Biological: AIN457;   Biological: Placebo
24 Recruiting Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Condition: Uveitis
Interventions: Drug: Placebo;   Drug: Dose 1 gevokizumab;   Drug: Dose 2 gevokizumab
25 Withdrawn Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis
Condition: Uveitis
Intervention: Biological: AIN457
26 Completed Phase III Study in Refractory Behcet's Disease
Condition: Behcet Disease
Interventions: Drug: AIN457;   Drug: Placebo
27 Terminated Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Biological: AIN457;   Biological: Placebo
28 Completed
Has Results
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
Conditions: Anterior Uveitis;   Uveitis
Intervention: Drug: Interferon Gamma-1b
29 Completed The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
Condition: Uveitis
Intervention: Drug: Interferon Gamma 1-b
30 Recruiting Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Drug: Placebo;   Drug: Dose 1 gevokizumab;   Drug: Dose 2 gevokizumab
31 Terminated Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
Condition: Non-infectious Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
32 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)
33 Completed Leflunomide to Treat Uveitis
Condition: Uveitis
Intervention: Drug: Leflunomide
34 Completed Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema
Conditions: Uveitis;   Glaucoma
Intervention:
35 Completed
Has Results
Multicenter Uveitis Steroid Treatment (MUST) Trial
Condition: Uveitis
Interventions: Drug: fluocinolone acetonide intraocular implant;   Drug: oral corticosteroid with immunosuppressive agents as needed

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years